PHARMACO
VIGILANCE

Committee

Pharmaco Vigilance Committee

Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. WHO established its Program for International Drug Monitoring in response to the thalidomide disaster detected in 1961. At the end of 2010, 134 countries were part of the WHO PV Program, India being one of them. PK Das Institute of Medical Sciences aims to enhance patient care and patient safety in relation to the use of medicines; and to support public health programs by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.

Objectives

Objectives of the Pharmacovigilance committee in PK Das Institute of Medical Sciences.

Pharmaco Vigilance Committee

2024-2025.

Click to view

Pharmaco Vigilance Committee

 2022-23.

Click to view